Choose Location

20-07-2020 (Singapore)

Register your interest


Register your interest


Pharma Licensing Agreements

20-21 July 2020 | Mandarin Orchard Hotel, Singapore

Book Now Register Your Interest Download Brochure

Early Bird Rate:  Register and Pay on or before 29 May 2020


Practical, Commercial, and with a focus on the ASEAN market, this course will take participants through key aspects of deal sourcing, structuring, and contracting, that ensure win – win outcomes for all parties in the transaction.

Using case studies, our expert course faculty will highlight risk management strategies, typical problem and dispute areas, and the right fix. It is recommended that both business development / licensing executives and legal managers from firms attend to maximise value.

Key Learning Outcomes & Case Studies Include

  • Licensing deal structures and components – a customised approach
  • Win-win negotiation strategies for all parties
  • Deal valuation and modeling based on projecting commercial returns
  • IP Contract structures applicable for the ASEAN market
  • Documentation practicalities
  • Key issues in cross border licensing
  • Dealing with foreground IP and background IP and the impact on business
  • Patent portfolio due diligence: Key considerations before acquisition
  • Post deal management
  • When the deal goes awry – exit strategies and legal matters

Who Should Attend

Licensing, Business Development, R&D, Commercial and Strategic planning executives from Pharma, Biotech, Government, CMOs, CDMOs and Investors / Financiers in the industry. Specific job functions including but not limited to:

  • Head of Business Development and Licensing
  • Corporate Development and In Licensing Manager
  • Director Global Business Development and Strategy
  • Strategy Planning
  • Commercial Managers/Directors
  • Chief Scientific Officer
  • Heads/Managers of R&D
  • CEOs and Heads of Investment
  • In house counsel/legal managers



Packages Price
2 Day TrainingSGD $3595SGD $3395Early BirdEarly Bird

Early Bird Rate:  Register and Pay on or before 29 May 2020

Register 2 Delegates & the 3rd attends FREE!
Group rate is based on normal rate of 2-day main conference package only.
For Group Registrations, email or call +65 6508 2401


  • Special Group Discount pricing is applicable to groups of 2 or more delegates from the same organisation registering for the same event, at the same time.
  • Fee stated is the discounted price PER DELEGATE. Only one discount applies – either the early bird rate OR the Special Group Discount.
  • All fees stated include luncheons, refreshments and complete set of documentation. It does not include the cost of accommodation and travel.
  • A 7% Goods & Services Tax (GST) is applicable to all Singapore based companies for Singapore venue.
  • View payment terms and bank transfer details, click here »


James Kinnaird
Partner, Marks & Clerk (Singapore)

James has particular expertise in assisting clients with the drafting and prosecution of applications in the pharmaceutical, chemical, food, life sciences and materials fields. He has managed and implemented strategies for protecting the inventions of pharmaceutical companies worldwide and spent a year advising a proposed, new business unit of AstraZeneca on its Freedom to Operate across multiple jurisdictions and products.

He is also heavily involved in helping pharmaceutical companies conduct due diligence in respect of patent portfolios that they are interested in acquiring or licensing. Recent examples of this include two licencing deals conducted by AUM Biosciences.

Areas of Expertise

  • Due diligence on patent portfolios before acquisition/licencing (buyer or seller)
  • Freedom to Operate
  • Product lwaunch risk identification/de-risking
  • Litigation Support
  • Intellectual property clause review in agreements and liaison with lawyers
  • Drafting, filing and prosecuting patent applications worldwide for pharmaceutical companies, ranging from large (Pfizer, AstraZeneca, BMS), medium (e.g. Orexo, Heptares Therapeutics) to small (e.g. AUM Biosciences, Betagenon)

James has a (BSc(Hons) Chemistry with Medicinal Chemistry from Glasgow University, PhD from Cambridge University). He initially followed the usual path for chemists with his background and spent time in the US doing postdoctoral work at Columbia University and as a medicinal chemist at Pfizer in Sandwich (UK), before switching track to become a patent attorney in 2005. He is now a Registered Singapore Patent attorney (2014), Chartered Patent Attorney (UK, 2009) and he was also a European Patent Attorney (qualified 2009) before his move to Singapore in 2013.



Wendy Low
Partner, Eldan Law

Wendy is the co-head of the IP practice of Eldan Law LLP, with a specialist focus in IP and technology related advisory and dispute. Between 2008 – 2017, she was a partner with the IP team of Rajah & Tann. She had been profiled as one of the “50 IP Litigators You Should Know” in the Asia Pacific region (Asia IP, September 2013) and had been consistently awarded the IP Star by Managing IP in 2014, 2015, 2016 and 2017.

Wendy’s practice focuses in copyright, trade mark, patent and confidentiality related disputes. She also has experience in IP prosecution, licensing and commercialisation work and provides IP and IT related advice to a range of clients including international conglomerates, SMEs, and government_linked organisations.

She regularly acts for international generic companies to defend patent infringement allegations arising out of their drug applications under the Health Products Act. She has also been engaged across a spectrum of medical and nutritional science related disputes, including in defending the CTO in a shareholders’ fallout in a start-up for a biomedical device and acting for an online medical website against a competitor for trademark infringement and passing off in using similar/ identical terms to generate Google Adword advertisements.

Wendy has aligned stakeholders across countries (particularly in ASEAN), levels and functions to ensure that solutions are driven towards business success. She regularly speaks on IP, franchising and licensing related topics across a range of local and international forums.

Digital Badge

Upon completion of this training course, participants will earn a digital badge.

Attend and participate in the 2 full days of training course duration, led by the designated training expert

Available to:
Seminar attendees

Digital Badge FAQ >


Pharma/Biotech Licensing – Evolution And Current Touch Points

  • Licensing as a source of new pipelines
  • Early and late stage drug development M&As and licensing needs
  • Tech driven licenses
  • Drug distribution licensing

The In/Out Licensing Deal Market In ASIAN

  • Trends and opportunities
  • Typical deal structures
  • Scope for innovation

The In/Out Licensing Process

  • Deal making components and structures
  • Territory, Loans, Field of use, upfront payments, royalty rates, development cost sharing, profit sharing, sales based milestones, co promotion rights, lead party
  • Strategy
  • The negotiation process
  • Contractual issues
  • Termination rights

Valuation Of Licensing Deals

  • Key factors
  • Criteria
  • Modeling the deal

Exercise: Using a spreadsheet, participants will model the optimal deal structure for a pharmaceutical compound to be licensed for commercialisation, followed by valuation

Structuring Biotech/Pharma Ip Contracts

  • Formation of contracts
  • Validity of contracts
  • Structure of a contract
  • Commercial considerations
  • Protecting IP – Patents, Trade marks, Passing off, Trade secrets/confidential information

IP Licenses

  • Form of IP Licence
  • Difference from assignment
  • Scope of use
  • Background IP
  • Dealing with foreground IP
  • Concerns of the IP Rights Owner/Licensor
  • Royalties/licence fees
  • Infringement
  • Wrongful use
  • Reputational damage
  • Sub-licensing
  • Reverse-engineering
  • Competition
  • Breach and termination

Exercise: Licensing Agreements For Immune Checkpoint Inhibitors

Concerns Of The IP Rights User / Licensee

  • Royalties/licence fees
  • Duration
  • Validity and geographic coverage
  • Extent of usage
  • Ownership of new developments
  • Licence fees
  • Infringement of third party IP rights
  • Breach and termination

Negotiating A Balanced License

  • Establishing intended outcomes
  • Relative bargaining positions
  • Identifying points of conflict and points of agreement
  • Win-win vs positional negotiation
  • Seven strategies of effective negotiations
  • Specific issues relating to negotiating an IP licence


  • Term Sheets
  • Confidential Prospectus
  • Non confidential brochure

Considerations For Cross Border Licensing

  • Choice of jurisdiction
  • Selecting governing law
  • The dispute resolution process

Post Deal Management

  • Project Management
  • Alliance Management
  • Patent infringement and arbitrations
  • Licensing agreement disputes

when & where

20 - 21 Jul 2020

Mandarin Orchard Singapore, by Meritus
333 Orchard Road, Singapore 238867
Tel: +65 6831 6062 | Fax: +65 6737 3130
Mobile No.: +65 8298 9442
Contact Person: Tan Ai Li

On-site & in-house training

Deliver this course how you want, where you want, when you want – and save up to 40%! 8+ employees seeking training on the same topic?

Talk to us about an on-site/in-house & customised solution.


Informa Connect is Singapore's leading event organiser. We conceive, develop and promote our own B2B industry conferences and corporate training courses, and offer tailored managed event solutions.

Find out more

COVID 19 Advisory from Informa
Learn More